Open AccessCardiovascular disease (CVD) risk scores, age, or years since menopause to predict cardiovascular disease in the Women's Health Initiative
Author(s) -
Robert A. Wild,
Kathleen M. Hovey,
Christopher A. Andrews,
Jennifer G. Robinson,
Andrew M. Kaunitz,
JoAnn E. Manson,
Carolyn Crandall,
Rachel Paragallo,
Chrisandra Shufelt,
C. Noel Bairey Merz
Publication year - 2021
Publication title -
menopause
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.086
H-Index - 103
eISSN - 1530-0374
pISSN - 1072-3714
DOI - 10.1097/gme.0000000000001753
Subject(s) - medicine , hazard ratio , menopause , proportional hazards model , medroxyprogesterone acetate , randomized controlled trial , placebo , framingham risk score , framingham heart study , clinical trial , disease , confidence interval , estrogen , pathology , alternative medicine
To assess the utility of cardiovascular disease (CVD) risk scores compared to age or years since menopause for prediction of CVD events in the WHI clinical trials.